Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model
Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL
IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity.
We have IRB approval to collected tissues from renal cell carcinoma patients.
The Marasco Lab Humanized Mouse Program is open to the research community We have IRB approval to collected tissues from renal cell carcinoma patients.
- 3I14 binds and neutralizes group 1 and 2 influenza A viruses and protects mice from lethal challenge
- 3I14 overlaps with or very close to the known stem epitopes of other broadly neutralizing antibodies
- 3I14 binding to the HA stem epitope leads to inhibition of HA0 cleavage and pH-dependent conformational changes
- Similar to other anti-stem broadly neutralizing antibodies, 3I14 engages an Fc-dependent immune-mediated mechanism
- Memory B cell evolution can expand the HA subtype specificity; evidence further suggests that establishing an optimized memory B cell pool should be an aim of "universal" influenza vaccine strategies
Ying Fu, Zhen Zhang, Jared Sheehan, Yuval Avnir, Callie Ridenour, Thomas Sachnik, Jiusong Sun, M. Jaber Hossain, Li-Mei Chen, Quan Zhu, Ruben O. Donis, Wayne A. Marasco. A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nature Communications, 2016; 7: 12780 DOI: 10.1038/ncomms12780
Superimposition of 3I14 model with FI6v3, d9.29 and MAb3.1. The heavy chain is in the blue, the light chain is in cyan. The HCDR3s and LCDR1s are indicated by the ovals. The residues in HCDR3 of 3I14, FI6v3, 39.29 and MAb 3.1 are colored in red, magenta, yellow and green, respectively.